CoChat

Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor α in Human Breast Carcinoma

Cooper, Charlton, Liu, Guang-Yu, Niu, Yu-Lian, Santos, Sylvia, Murphy, Leigh C., Watson, Peter H. · 2004 · Clinical Cancer Research

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Purpose: Hypoxia may influence gene expression to promote malignancy, and acute hypoxia has been shown to transiently repress estrogen receptor (ER)-α expression in breast cell lines. However, the effect of intermittent hypoxia, which is likely more prevalent in breast cancers, remains to be determined. Experimental Design: ER-α expression was assessed by Western blot and immunohistochemistry in a selected cohort of 51 ER-α–positive breast carcinomas, in relation to markers of hypoxia. The effect of acute and intermittent hypoxia on ER-α expression was also determined in MCF7 and ZR-75 breast cell lines, together with the role of proteasome function with the proteasome inhibitor bortezomib. Results: Regional loss of ER-α expression occurs in breast tumors and is consistently present in hypoxic regions defined by the proximity of necrosis and induction of hypoxia-induced genes carbonic anhydrase IX (CA-IX) and glucose transporter 1 (Glut-1), in both in situ (n = 29; P < 0.0001) and invasive (n = 20; P = 0.0001) carcinomas. In MCF7 and ZR-75 cells, ER-α is transiently down-regulated by acute hypoxia and rapidly restored by reoxygenation. However, intermittent, acute hypoxia can cause a similar down-regulation of ER-α that is not attributable to decreased mRNA and persists in MCF7 cells despite reoxygenation for up to 14 days. This effect occurs with no change in cell viability but a corresponding reduction in growth response to estradiol. However, ER-α expression can be restored by bortezomib. Conclusions: Intermittent hypoxia can cause persistent changes in proteasome function that may contribute to reduced ER-α expression in breast tumors and consequently to diminished response and development of resistance to endocrine therapy.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-04-1235

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Cited by

See all 64

Metadata

Authors
Cooper, C., Liu, G.-Y., Niu, Y.-L., Santos, S., Murphy, L. C., & Watson, P. H.
Affiliations
  • 1Pathology and Manitoba Institute of Cell Biology and Departments of
  • Shanghai Medical College of Fudan University (CN)
  • University of Manitoba (CA)
Venue
Clinical Cancer Research
Published
2004-12-15
Volume
10
Issue
24
Pages
8720-8727
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2163700401
Cited by
64
References
31
Citations by year
2024: 2 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 4 · 2016: 2 · 2015: 4 · 2014: 5 · 2013: 3 · 2012: 5
FWCI
1.25
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
intermittent hypoxia, estrogen receptor alpha, breast cancer, proteasome, bortezomib, acute hypoxia, reoxygenation, carbonic anhydrase IX, glucose transporter 1, tumor hypoxia, endocrine therapy resistance, estradiol response, MCF-7 cells
MeSH terms
Bortezomib, Carbonic Anhydrase IX, Antigens, Neoplasm, Boronic Acids, Breast Neoplasms, Carbonic Anhydrases, Carcinoma, Intraductal, Noninfiltrating, Cell Survival, Female, Humans, Immunoenzyme Techniques, Monosaccharide Transport Proteins, Neoplasm Invasiveness, Oxygen, Protease Inhibitors, Pyrazines, Tumor Cells, Cultured, Blotting, Western, Down-Regulation, Cell Hypoxia, Proteasome Endopeptidase Complex, Estrogen Receptor alpha, Glucose Transporter Type 1, Proteasome Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor α in Human Breast Carcinoma. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-04-1235
The paper
Cooper, C., Liu, G.-Y., Niu, Y.-L., Santos, S., Murphy, L. C., & Watson, P. H. (2004). Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor α in Human Breast Carcinoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-04-1235

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.